Prophylactic Hepatitis B Virus Vaccines Market : Global Industry Analysis and Forecast 2016 - 2024

Prophylactic Hepatitis B Virus Vaccines Market : Global Industry

Analysis and Forecast 2016 - 2024

Persistence Market Research

Prophylactic Hepatitis B Virus Vaccines

Market : Global Industry Analysis and

Forecast 2016 - 2024

Persistence Market Research

1

Prophylactic Hepatitis B Virus Vaccines Market : Global Industry

Analysis and Forecast 2016 - 2024

Persistence Market Research Released New Market Report on “Prophylactic Hepatitis B

Virus Vaccines Market : Global Industry Analysis and Forecast 2016 - 2024”.

Hepatitis B virus (HBV) is disease related to the liver. Hepatitis B virus (HBV) infection results in

deaths due to liver cancer and liver failure. The hepatitis B vaccine is available for all age

groups to prevent HBV infection. The disease is caused due to transmission of Hepatitis B virus

(HBV) through contact with body fluids, blood and semen of an infected person. Hepatitis B

disease can cause acute and later may turn to chronic disease if not treated at early stage. In

2015, WHO estimated that 240 Mn people are infected with chronic hepatitis B virus. Every year

more than 780,000 deaths occur due to complexity of hepatitis B viral infection. This infection

caused by chronic hepatitis B virus develops fulminant hepatitis B (autoimmune disorder), liver

cirrhosis, hepatocellular carcinoma (liver cancer), liver failure which can be treated by a liver

transplant. The Global Alliance for Vaccines and Immunization (GAVI) provides direction and

support to prevent transmission through vaccination. However, there is a significant decrease in

incidence of hepatitis B virus infection after introduction of hepatitis B vaccine.

The prophylactic hepatitis B virus vaccines market is expected to grow remarkably during the

forecast period due to increasing prevalence and incidence of hepatitis B infection, increasing

public awareness (Patient Education Programs), government initiatives for promotion and

creating awareness about prophylactic hepatitis B vaccines....